Clinical results from vaccination with recombinant grass pollen allergens

Clinical and Developmental Immunology

Volumn 13, Issue 2-4, 2006, Pages 389-394

  Jutel, Marek ^a,c   Cromwell, Oliver ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b ALLERGOPHARMA JOACHIM GANZER KG   (Germany)

^c Department of Internal Medicine and Allergology ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; COMPLEMENTARY DNA; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G4; MESSENGER RNA; PHLEUM PRATENSE 1 ALLERGEN; PHLEUM PRATENSE 10 ALLERGEN; PHLEUM PRATENSE 13 ALLERGEN; PHLEUM PRATENSE 2 ALLERGEN; PHLEUM PRATENSE 5A ALLERGEN; PHLEUM PRATENSE 5B ALLERGEN; PHLEUM PRATENSE 6 ALLERGEN; PHLEUM PRATENSE 7 ALLERGEN; PLACEBO; PLASMID DNA; POLLEN ANTIGEN; PROFILIN; RECOMBINANT GRASS POLLEN ALLERGEN;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA VECTOR; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ELECTROPHORESIS; GENERAL URTICARIA; HUMAN; IMMUNOBLOTTING; IMMUNOTHERAPY; INJECTION SITE ERYTHEMA; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; INSECT ALLERGY; LOCAL URTICARIA; MAJOR CLINICAL STUDY; POLLEN ALLERGY; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; TREATMENT RESPONSE; URTICARIA; VACCINATION;

ALLERGENS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; POACEAE; POLLEN; RECOMBINANT PROTEINS; VACCINATION;

EID: 33845613856     PISSN: 17402522     EISSN: 10292357     Source Type: Journal    
DOI: 10.1080/17402520600576586     Document Type: Article

References (18)

1. Andersson K, Lidholm J. 2003. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol 130(2):87-107.
2. Batard T, Didierlaurent A, Chabre H, Mothes N, Bussieres L, Bohle B, et al. 2005. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy. Int Arch Allergy Immunol 136(3):239-249.
3. Bauchau V, Durham SR. 2004. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Resp J 24(5):758-764.
4. Crameri R. 1998. Recombinant Aspergillus fumigatus allergens: From the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 115(2):99-114.
5. Crameri R, Jaussi R, Menz G, Blaser K. 1994. Display of expression products of cDNA libraries on phage surfaces. A versatile screening for selective isolation of genes by specific gene-product/ligand interaction. Eur J Biochem 226:53-58.
6. Cromwell O, Suck R, Kahlert H, Nandy A, Weber B, Fiebig H. 2004. Transition of recombinant allergens from bench to clinical application. Methods 32(3):300-312.
7. Horvath H, Huang J, Wong O, Kohl E, Okita T, Kannangara CG, et al. 2000. The production of recombinant proteins in transgenic barley grains. Proc Natl Acad Sci USA 97(4):1914-1919.
8. Jacquet A, Magi M, Petry H, Bollen A. 2002. High-level expression of recombinant house dust mite allergen Der p 1 in Pichia pastoris. Clin Exp Allergy 32(7):1048-1053.
9. Juniper EF, Guyatt GH. 1991. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21(1):77-83.
10. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. 2005. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 116(3):608-613.
11. Osterballe O. 1980. Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of Timothy grass pollen. A controlled double-blind study. In vivo variables, season I. Allergy 35:473-489.
12. Osterballe O, Lowenstein H, Prahl P, Skov P, Weeke B. 1981. Immunotherapy in hay fever with two major allergens 19, 25 and partially purified extract of Timothy grass pollen. A controlled double blind study. In vitro variables, season I. Allergy 36:183-199.
13. Rossi RE, Monasterolo G, Monasterolo S. 2001. Measurement of IgE antibodies against purified grass-pollen allergens (Ph1 p 1, 2, 3, 4, 5, 6, 7, 11 and 12) in sera of patients allergic to grass pollen. Allergy 56(12):1180-1185.
14. Suck R, Petersen A, Becker WM, Cromwell O. 2003. Native PAGE. 2003 is an excellent tool for investigation of natural and recombinant low molecular weight grass pollen allergens, Abstract Book EAACI 2003 58 [Suppl.74], 36. Ref. type: Abstract.
15. Suphioglu C. 2000. What are the important allergens in grass pollen that are linked to human allergic disease? Clin Exp Allergy 30(10):1335-1341.
16. Trivedi B, Valerio C, Slater JE. 2003. Endotoxin content of standardized allergen vaccines. J Allergy Clin Immunol 111(4):777-783.
17. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. 1999. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). [68 refs.] Clin Exp Allergy 29(7):896-904.
18. Wagner B, Fuchs H, Adhami F, Ma Y, Scheiner O, Breiteneder H. 2004. Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana. Methods 32(3):227-234.